“Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice”, FE, vol. 9, no. 4, pp. 173–181, Jan. 2008, doi: 10.7175/fe.v9i4.235.